MeVis Medical Solutions AG (FRA:M3V) PEG Ratio: N/A (As of Jul. 06, 2026)


FRA:M3V MeVis Medical Solutions AG FRA:M3V
66 GF Score
Price €24.00
GF Value €22.72
! 5 Warning Signs
View Full Analysis

What is MeVis Medical Solutions AG PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, MeVis Medical Solutions AG's PE Ratio without NRI is 57.28. MeVis Medical Solutions AG's 5-Year EBITDA growth rate is -8.70%. Therefore, MeVis Medical Solutions AG's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for MeVis Medical Solutions AG's PEG Ratio or its related term are showing as below:


During the past 13 years, MeVis Medical Solutions AG's highest PEG Ratio was 1.29. The lowest was 0.54. And the median was 0.89.


FRA:M3V's PEG Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.41
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


MeVis Medical Solutions AG  (FRA:M3V) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


MeVis Medical Solutions AG PEG Ratio Related Terms


MeVis Medical Solutions AG PEG Ratio Historical Data

* Premium members only.

The historical data trend for MeVis Medical Solutions AG's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeVis Medical Solutions AG PEG Ratio Chart

MeVis Medical Solutions AG Annual Data
Trend Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MeVis Medical Solutions AG Semi-Annual Data
Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:M3V vs VEEV, BTSG, TEM: PEG Ratio Comparison

For the Health Information Services subindustry, MeVis Medical Solutions AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeVis Medical Solutions AG PEG Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's PEG Ratio distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's PEG Ratio falls into.


FRA:M3V
66GF Score
MeVis Medical Solutions AG FRA:M3V
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MeVis Medical Solutions AG PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

MeVis Medical Solutions AG's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=57.27923627685/-8.70
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?

Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued. The current stock price of €24.00 is trading 5.6% above its estimated GF Value™ of €22.72.

Key valuation signals for FRA:M3V:

  • PEG Ratio: N/A
  • GF Value™: €22.72 vs. price of €24.00 (5.6% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MeVis Medical Solutions AG Business Description

Other Exchanges 0HI7:UKM3V:Germany
Address Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score

Get the complete analysis for FRA:M3V

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€24.00
Price
€22.72
GF Value